Abdulkareem I Kraidy, MD General Practice Medicare: May Accept Medicare Assignments Practice Location: 6801 Backlick Rd, Springfield, VA 22150 Phone: 240-417-6424 |
Saurabh Kumar Varma, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 5501 Backlick Rd Ste 118, Springfield, VA 22151 Phone: 252-314-4657 |
News Archive
It remains an unresolved question whether adult patients with Hodgkin's lymphoma, a certain type of lymph node cancer, benefit from allogeneic stem cell transplantation (SCT) with an unrelated donor. This is due to the fact that studies are lacking that compare this therapy with autologous transplantation or conventional chemotherapy without SCT.
Wyse Technology, the inventor and global leader in cloud client computing, today announced its partnership and continued success with The Leukemia and Lymphoma Society, the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services.
GOP presumptive presidential nominee Mitt Romney will make campaign appearances Monday in Florida, the senior-rich state where Medicare is a key voter concern, and where some predict Paul Ryan's budget proposals could have a negative impact. Meanwhile, the newly anointed Romney vice presidential pick will be in Iowa.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
The results of the much awaited BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with CAD and left ventricULar dysfunction) trial have shown that coronary artery disease (CAD) patients with left ventricular dysfunction (LVD) and a heart rate more than 70 bpm have a significantly higher risk of cardiovascular death and other cardiovascular events and in these patients (heart rate above 70 bpm) treatment with ivabradine further reduces the risk of the most important coronary events such as fatal and non-fatal myocardial infarction and coronary revascularisation by one third, even when these patients are already receiving optimal therapy.
› Verified 2 days ago